Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
3
×
national blog main
national top stories
new york blog main
new york top stories
startups
3
×
abbvie
astrazeneca
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
covid-19
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
takeda pharmaceutical
texas blog main
texas top stories
unity biotechnology
venture capital
What
ceo
3
×
acquisitions
bio
daniel
gilead
medicines
o’day
roundup
sciences
aims
announced
backed
biggest
build
buy
cause
collabs
company’s
covid
deal
debut
drug
drugs
dyne’s
epilepsy
genes
genetic
gilead’s
help
introduce
ipo
links
marcio
microbiome
month
moves
mutations
neuro
new
openly
Language
unset
3
×
Current search:
unset
×
startups
×
" life sciences "
×
ceo
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More